Clinical Trials Directory

Trials / Terminated

TerminatedNCT02471703

Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem

Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem A Prospective, Consecutive Series, Multi-center Clinical Study

Status
Terminated
Phase
Study type
Observational
Enrollment
126 (actual)
Sponsor
Smith & Nephew, Inc. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, consecutive series, multicenter clinical study of clinical outcomes following total hip arthroplasty with the SMF stem.

Detailed description

The objectives of this study are to evaluate the safety and efficacy of the study device. This study will document any device-related, surgical or post-operative complication and adverse radiographic observations. Improvement in pain, function, and health economic data will be compared with improvements documented with other joint systems. Outcome measures will be quantified through statistical analysis of study device , HOOS questionnaire, radiographic assessments, Harris Hip Score, and adverse event reports.

Conditions

Interventions

TypeNameDescription
DEVICETotal hip arthroplastyTotal hip arthroplasty

Timeline

Start date
2008-02-27
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2015-06-15
Last updated
2021-02-21

Locations

6 sites across 3 countries: Belgium, Canada, Germany

Source: ClinicalTrials.gov record NCT02471703. Inclusion in this directory is not an endorsement.

Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem (NCT02471703) · Clinical Trials Directory